Market Access represents one of the most critical barriers to patients accessing the therapies they need. Health insurers restrict patient access to therapies that carry less value for them, posing an obvious challenge to drug makers. The IQVIA Ma
Market Access represents one of the most critical barriers to patients accessing the therapies they need. Health insurers restrict patient access to therapies that carry less value for them, posing an obvious challenge to drug makers. The IQVIA Ma